Biotechnology ChemoCentryx Reports Pharmacokinetic and Pharmacodynamic Results from Ongoing Phase I Trial of Orally Administered PD-L1 Inhibitor, CCX559, at American Association for Cancer Research (AACR) Annual Meeting 2022 April 13, 2022
Biotechnology BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 4, 2022, TO ANNOUNCE THIRD QUARTER 2022 FINANCIAL RESULTS April 13, 2022
Biotechnology Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader April 13, 2022
Biotechnology Allogene Therapeutics Announces Participation in Seven Upcoming Investor Conferences April 12, 2022
Search
Biotechnology
